<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html>
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>Stomach HER2</title>
<link rel="stylesheet" type="text/css" href="view.css" media="all">
<script type="text/javascript">
function updateDescription (frm) 
{
    var Template = ""

if (frm.A05.value !== ""){
	Template += "- HER2 IHC (for biopsy): " + frm.A05.value + "\n";
};

if (frm.A06.value !== ""){
	Template += "  - Score : " + frm.A06.value + "\n";
};

if (frm.A07.value !== ""){
	Template += "- HER2 IHC (for excision): " + frm.A07.value + "\n";
};

if (frm.A08.value !== ""){
	Template += "  - Score : " + frm.A08.value + "\n";
};

if (frm.A09.value !== ""){
	Template += "- HER2 DISH : " + frm.A09.value + "\n";
};

if (frm.A10.value !== ""){
	Template += "  - Number of tumor cell counted : " + frm.A10.value + "\n";
};

if (frm.A11.value !== ""){
	Template += "  - Average number of HER2 signals (black) per cell : " + frm.A11.value + "\n";
};

if (frm.A12.value !== ""){
	Template += "  - Average number of CEP17 signals (red) per cell : " + frm.A12.value + "\n";
};

if (frm.A13.value !== ""){
	Template += "  - HER2/CEP17 ratio : " + frm.A13.value + "\n";
};

if (document.getElementById("A14").checked || document.getElementById("A15").checked){
	Template += "  - Other ISH abnormalities: "  + "\n";
}

if (document.getElementById("A14").checked){
	Template += frm.A14.value + "\n";
}

if (document.getElementById("A15").checked){
	Template += frm.A15.value + "\n";
}

if (frm.A18.value !== ""){
	Template += "- Fixation time in buffered formalin : " + frm.A18.value + "\n";
};

if (frm.A19.value !== ""){
	Template += "- Additional notes: " + "\n" + "  - " + frm.A19.value + "\n";
};


if (frm.A05.value + frm.A07.value !== ""){
	Template += "\n" + "Formalin-fixed paraffin embedded sections were assessed by IHC technique, using Ventana monoclonal HER2/neu (4B5) with Ventana BenchMark ULTRA multimer detection system.";
};


if (frm.A09.value !== ""){
	Template += "\n" + "Dual ISH was performed on formalin-fixed paraffin embedded section with the Ventana INFORM HER2 Dual ISH DNA Probe Cocktail Assay on automated system, and examined by pathologist under light microscopy.";
}; 
  

frm.holdtext.value = Template;
}


function CopyToClipboard() {
  /* Get the text field */
  var copyText = document.getElementById("holdtext");

  /* Select the text field */
  copyText.select();

  /* Copy the text inside the text field */
  document.execCommand("copy");

  /* Alert the copied text */
  alert("Report copied to clipboard");
}
</script>
<script type="text/javascript" src="view.js"></script>
</head>

<body>
<img id="top" src="top.png" alt="">
	<div id="form_container">
	<div class="form_description">
		<h2><a href=".\cap\cp-gastric-HER2biomarker17-1001.pdf" target="_blank">
		<div class="tooltip">
		Stomach HER2 test
		<span class="tooltiptext">click to access explanations in the original CAP template</span>
		</div>
		</a></h2>

		</div>

	<form>

<p>
<fieldset style="border-color:#e6e6ff;">
<li>	
<p>
<label class="description">- HER2 IHC for <a href=".\cap\StomachHER2_CAP_ACCP_ASCO.pdf" target="_blank">biopsy (> or = 5 cancer cell clusters)</a> :</label>
	<select class="element select medium"  ID="A05">
		<option value=""></option>
		<option value="Cannot be determined">Cannot be determined</option>
		<option value="Negative for over-expression">Negative for over-expression</option>
		<option value="Equivocal for over-expression">Equivocal for over-expression</option>
		<option value="Positive for over-expression">Positive for over-expression</option>
	</select>
</p>

<p>
<label>- Score:</label><br>
	<select class="element select small"  ID="A06">
		<option value=""></option>
		<option value="0 Negative(No reactivity or no membranous reactivity in any cancer cell)">0 Negative (No reactivity or no membranous reactivity in any cancer cell)</option>
		<option value="1 Negative (Cancer cell cluster, > or = 5 cells, with a faint or barely perceptible membranous reactivity irrespective of percentage of cancer cells positive)">1 Negative (Cancer cell cluster, > or = 5 cells) with a faint or barely perceptible membranous reactivity irrespective of percentage of cancer cells positive)</option>
		<option value="2 Equivocal (Cancer cell cluster, > or = 5 cells, with a weak to moderate complete, basolateral, or lateral membranous reactivity irrespective of percentage of cancer cells positive)">2 Equivocal (Cancer cell cluster, > or = 5 cells, with a weak to moderate complete, basolateral, or lateral membranous reactivity irrespective of percentage of cancer cells positive)</option>
		<option value="3 Positive (Cancer cell cluster, > or = 5 cells, with a strong complete basolateral, or lateral membranous reactivity irrespective of percentage of cancer cells positive)">3 Positive (Cancer cell cluster, > or = 5 cells, with a strong complete basolateral, or lateral membranous reactivity irrespective of percentage of cancer cells positive)</option>
	</select>
</p>
</li>

<li>
<p>
<label class="description">- HER2 IHC for <a href=".\cap\StomachHER2_CAP_ACCP_ASCO.pdf" target="_blank">excision (10% cancer cells)</a> :</label>
	<select class="element select medium"  ID="A07">
		<option value=""></option>
		<option value="Cannot be determined">Cannot be determined</option>
		<option value="Negative for over-expression">Negative for over-expression</option>
		<option value="Equivocal for over-expression">Equivocal for over-expression</option>
		<option value="Positive for over-expression">Positive for over-expression</option>
	</select>
</p>

<p>
<label>- Score:</label><br>
	<select class="element select small"  ID="A08">
		<option value=""></option>
		<option value="0 Negative (No reactivity or membranous reactivity in < 10% of cancer cells)">0 Negative (No reactivity or membranous reactivity in < 10% of cancer cells)</option>
		<option value="1 Negative (Faint or barely perceptible membranous react ivity in > or = 10% of cancer cells; cells are reactive only in part of their membrane)">1 Negative (Faint or barely perceptible membranous react ivity in > or = 10% of cancer cells; cells are reactive only in part of their membrane)</option>
		<option value="2 Equivocal (Weak to moderate complete, basolateral or lateral membranous reactivity in > or = 10% of tumor cells)">2 Equivocal (Weak to moderate complete, basolateral or lateral membranous reactivity in > or = 10% of tumor cells)</option>
		<option value="3 Positive (Strong complete, basolateral or lateral membranous reactivity in > or = 10% of cancer cells)">3 Positive (Strong complete, basolateral or lateral membranous reactivity in > or = 10% of cancer cells)</option>
	</select>
</p></li>
<br>
</fieldset>
</p>

<p>
<fieldset style="border-color:#e6e6ff;">
<li>
<p>
<label class="description">- <a href=".\cap\StomachHER2_CAP_ACCP_ASCO.pdf" target="_blank">HER2/neu oncoprotein DISH:</a> </label>
	<select class="element select medium"  ID="A09">
		<option value=""></option>
		<option value="Cannot be determined">Cannot be determined</option>
		<option value="Negative for HER2 amplification">Negative for HER2 amplification</option>
		<option value="Positive for HER2 amplification">Positive for HER2 amplification</option>
	</select>
</p>

<p>
- Number of tumor cell counted :
<input type="text" ID="A10" class="element text small" size="10">
</p>

<p>
- Average number of HER2 signals (black) per cell :
<input type="text" ID="A11" class="element text small" size="10">
</p>

<p>
- Average number of CEP17 signals (red) per cell :
<input type="text" ID="A12" class="element text small" size="10">
</p>

<p>
- HER2/CEP17 ratio :
<input type="text" ID="A13" class="element text small" size="10">
</p>

<p>
- Other ISH abnormalities:<br> 
	<input type="checkbox" id="A14" class = "element checkbox" value="    - Aneusomy"><label class="element choice">Aneusomy</label>
	<input type="checkbox" id="A15" class = "element checkbox" value="    - Heterogeneous signals"><label class="element choice">Heterogeneous signals</label>
</p>
</li>
<br>
</fieldset></p>
<li>
<p>
<label>- Fixation time in buffered formalin :</label><br>
	<select class="element select medium"  ID="A18">
		<option value=""></option>
		<option value="Optimal fixation (6-72 hours)">Optimal fixation (6-72 hours)</option>
		<option value="Prolonged intervals (> 72 hours)">Prolonged intervals (> 72 hours)</option>
		<option value="Uncertain">Uncertain</option>
	</select>
</p></li>

<li><p>
<label class="description">- Additional notes:</label>
 <textarea ID="A19" class = "element textarea medium" style="border-color:grey;"></textarea> 
</p></li>


<br><br>
<input type="button" name="copyform" value="Check your Report" onclick="updateDescription(this.form)"/>
<br>
<TEXTAREA ID="holdtext" name="holdtext" class="textarea large" style="border-color:coral;"></TEXTAREA>

<br><br>
<!-- The button used to copy the text -->
<button onclick="CopyToClipboard()">Copy text to Clipboard</button>

<input type="reset" value="Reset Form" name="reset" style="float: right;">
</form>
<br>
<br>

<div id="footer">
Last upated 12-Dec-2019, based on <a href="https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates" target="_blank">US CAP cancer protocol templates</a>.<br>
html form was created on <a href="https://www.phpform.org">pForm</a>, <a href="https://www.w3schools.com/">W3 School</a>, <a href="https://stackoverflow.com/">StackOverflow</a>, and <a href="https://icons8.com">Icons8</a>.<br><br>
Anatomical Pathology Division, Queen Mary Hospital, Hong Kong.
</div>
<img id="bottom" src="bottom.png" alt="">
</body>
</html>

